Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Lattice Semiconductor Corporation Common Stock (LSCC) Price & Performance

Inovio Pharmaceuticals IncTrade
Lattice Semiconductor Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Lattice Semiconductor Corporation Common Stock — how do they compare? Inovio Pharmaceuticals Inc trades at $1.11 (market cap $119.42M), while Lattice Semiconductor Corporation Common Stock trades at $127.5 (market cap $18.61B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 155.8× Inovio Pharmaceuticals Inc's market cap, and Lattice Semiconductor Corporation Common Stock is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and Lattice Semiconductor Corporation Common Stock for 0 Days on average.

INOLSCC
Market Cap
$119.42M$18.61B
Volume
2,789,6491,778,419
Sector
HealthTechnology
52-Week High
$2.65$155.27
52-Week Low
$0.66$61.73
Typical Hold Time
43 Days0 Days
Enterprise Value
$90.75M$18.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Inovio Pharmaceuticals Inc

INO trades at $1.09, down 3.54% on the day, with a bearish technical signal driven by moving averages. The company reported a net loss of $84.95 million in 2025 on minimal revenue of $65,340, with negative profitability metrics, but has beaten EPS estimates in recent quarters. Key near-term catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107.

The investment case hinges on regulatory approval of INO-3107, with a consensus price target of $2.75 implying significant upside. However, extreme financial losses, high cash burn, and dependence on dilutive financing pose substantial risks. Analyst sentiment is cautiously optimistic but reflects high uncertainty.

Lattice Semiconductor Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INO
95% Buy5% Sell
Avg holding period · 43 Days
LSCC
100% Buy0% Sell
Avg holding period · 0 Days

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO →

About Lattice Semiconductor Corporation Common Stock

Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.

Read more on LSCC →